International Patent: HYDROXYCHLOROQUINE AS A PRETREATMENT TO ENHANCE AAV DELIVERY OF BROADLY NEUTRALIZING MONOCLONAL ANTIBODIES

GENEVA, July 2 -- UNIVERSITY OF MIAMI filed a patent application (US2025/054576) for “HYDROXYCHLOROQUINE AS A PRETREATMENT TO ENHANCE AAV DELIVERY OF BROADLY NEUTRALIZING MONOCLONAL ANTIBODIES”. With publication no. WO/2026/102264, here are the other details related to the patent application:

Kind: Later publication of international search report [A3]

IPC: C07K 16/114

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....